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Abstract: Background U.S. healthcare spending will reach 20% of GDP by 2026. Despite this spending, almost 14% of our
under-65 population still lacks health insurance and out-of-pocket healthcare spending is high. To date, much of the healthcare
reform debate has focused on who pays—the government, employers or individuals. Objective To review current healthcare
reform issues and evidence. Method We address the questions of how much we pay, how we pay and what we receive for the
money as a potential foundation for constructive dialogue. Results U.S. healthcare spending continues to exceed that of other
countries, without offering universal coverage. Notwithstanding coverage expansions implemented under the Affordable Care
Act, uninsurance rates have been rising. Rapid growth of high deductible plans has also significantly increased rates of
underinsurance. There is very little evidence that specific policies or interventions employed to date will significantly reduce cost,
especially under a fee for service system, where volume makes up for cuts. Global risk payments hold the greatest promise for
real cost containment because they can drive true delivery system reform. Conclusion Meaningful, long-term healthcare reform
cannot be successful until comprehensive, evidence-based policies that address healthcare costs are fully embraced and
implemented.

Keywords: Healthcare Reform, Healthcare Cost, U.S. Healthcare System, Access and Coverage

1. Introduction
U.S. healthcare spending will reach 20% of GDP by 2026
[1]. Despite this spending, almost 14% of the U.S. under-65
population still lack health insurance [2]. Because
out-of-pocket costs for healthcare are high and continue to go
up, an increasing number of insured Americans are having
difficulty accessing comprehensive care. The plight of those
who lack insurance (uninsured) and those who lack adequate
insurance (underinsured) cannot be ignored.
To date, much of the healthcare reform debate in the U.S.
has focused on who pays—the government, employers or
individuals. Ultimately, the American people pay in one way
or the other: through taxes, paycheck deductions, benefits in
lieu of wages, or straight out of pocket. The real questions
should not be who pays but should be how much can the

American public can afford to pay, how they pay and what
they receive for the money. Healthcare reform will not be
successful in the U.S. until comprehensive, evidence-based
policies are fully embraced and implemented. The root causes
of the American health system’s problems must be clearly
articulated, openly and publicly debated and addressed in
order to develop a rational delivery model rather than one that
just rations care.

2. Skyrocketing Costs: Implications and
Consequences
In the U.S., the Medicaid program is funded jointly between
state and federal governments to provide coverage for
low-income populations. Medicaid accounted for 19.6% of

Journal of Family Medicine and Health Care 2020; 6(1): 24-30

spending from state general funds in 2016, more than doubling
since 1990 (9.6%) [3]. States that adopted Medicaid expansion
under the Affordable Care Act (ACA) are particularly
challenged since they now must cover the full 10% of
expansion costs. Since most states cannot carry deficits from
year to year because of balance budget requirements, they are
forced to either raise more money (taxes) or cut spending
somewhere else. This fiscal reality has forced state lawmakers
to make some very painful decisions, and state-level
healthcare reform may be the frontline in generating effective
models for a restructured healthcare delivery system.
The U.S. federal government is not immune to the fiscal
pain of high healthcare spending. The federal government
spent nearly $1.1 trillion on health care in fiscal year 2018
(27% of the federal budget) [4]. Since employer and
employee health insurance contributions are exempt from
federal taxes, the government lost an additional $280 billion
per year in tax revenue. The U.S. federal deficit now exceeds
a trillion dollars and is projected to grow; this level of
spending will ultimately demand healthcare spending cuts.
Despite these massive financial commitments, the health
status of Americans lags behind that of citizens in many other
advanced countries, even though these countries spend
substantially less on healthcare. For example, the U.S. ranks
24th in infant mortality and 28th in life expectancy at birth,
falling behind most European countries [5]. Interestingly,
countries with better health statistics tend to spend
considerably more on social programs that address poverty
and the social determinants of health (SDOHs), such as food
security, housing adequacy, and education [6]. In fact, total
spending on all social programs including healthcare is
comparable between the U.S. and other countries with better
health outcomes. Our spending approach just does not yield
the bang for the buck in terms of health outcomes.
The impact of healthcare spending on the competitiveness
of U.S. companies is also significant. Employer-sponsored
(family) health insurance premiums rose more than 50%
between 2008 ($12,680) and 2018 ($19,616) [7]. Since
employers currently pay about 72% of premiums, healthcare
costs translate into reduced profits for U.S. companies. Warren
Buffett described healthcare as “…a hungry tapeworm eating
away at American companies” [8]. Many companies have
responded by shifting healthcare costs to their employees. In
2018, covered workers contributed, on average, 18% of the
premium for single coverage and 29% for family coverage.
Between 2006 and 2016, deductibles rose from an average of
$303 to over $1,200. High deductible plans have become
commonplace, covering 44% of adults ages 18-64 in 2017 and
the percentage is projected to increase. Some companies,
especially small (3-24 employees) and medium size firms
(25-199), have simply stopped offering health insurance to
their employees. In 2018, only 57% of U.S. companies offered
health insurance to their employees, down from a high of 69%
in 2010. Many American companies have also shifted jobs
outside the U.S. to take advantage of lower compensation
costs, including low or zero healthcare costs.
Current healthcare costs also make healthcare unaffordable
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for millions of Americans and result in significant health
disparities. In 2017, personal healthcare expenditures
averaged $9,106 per person in the U.S., or roughly $36,424 for
a family of four [9]. Comparing this amount to the U.S. federal
poverty line [10] for this family size ($24,600) and the median
household income ($61,400) for 2017, the challenge becomes
clear: most U.S. families cannot afford healthcare on their own.
One in five working-age Americans with health insurance still
reported problems paying medical bills in the past year,
according to a Kaiser Family Foundation/New York Times
survey [11]. Medical expenses have become a significant
source of personal bankruptcy. Concerns over healthcare costs
have become a middle-class issue and not just a problem of the
poor.
Why does the U.S. spend so much money on healthcare?
The most obvious culprit is the U.S. fee for service (FFS)
payment system. There is simply no incentive to reduce
utilization. In fact, quite the opposite: do more, get more. This
incentive for volume can subliminally impact the behavior of
even the most ethical, dedicated providers. The FFS payment
system must be totally replaced by a reimbursement system
that rewards efficiency and quality-value. A revised
reimbursement system will drive the development of new
delivery models that ensure access to high value care, focused
on improving and preserving health and discouraging
low-value care.
Part of the American over-utilization also stems from
cultural attitudes and patient demand for access and choice
engendered by the era of indemnity coverage when insurance
paid for almost all services regardless of price and known
efficacy. Many view unfettered access to healthcare as a right
and reject the concept that healthcare is a critical public
commodity that must be effectively and efficiently managed
for the benefit of all. Until recently, U.S. insurance plans
offered low copays, deductibles and out-of-pocket maximums,
giving patients little financial incentive to curb unfettered use.
Politicians have either directly or indirectly reinforced the
demand for choice. During the debate about Obamacare, both
parties promised that “no one should get between you and
your doctor”.
But some experts say that the U.S. spending on healthcare is
a lot less about volume and waste and a lot more about prices.
In a 2003 Health Affairs article, a group of economists showed
that, aside from a few high-tech services, Americans actually
use less healthcare than residents of other industrialized
countries: fewer hospital days and fewer physician office
visits [12]. U.S. high healthcare spending is actually the result
of much higher prices. For example, a recent study from
Kaiser Family Foundation found that the average price of an
angioplasty was $31,620 in the U.S.--far higher than Australia
($11,164), Switzerland ($10,066) or the U.K. ($7,264) [13].
Similarly, C-section deliveries cost an average of $16,106 in
the U.S., compared to $9,965 in Switzerland and $7,901 in
Australia.
The bottom line is that U.S. healthcare costs continue to
spiral out of control. The rapid growth of high deductible and
catastrophic plans means that individuals with insurance pay
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more out of pocket for less comprehensive coverage,
potentially adversely impacting their health and healthcare.
Measures of the health of the U.S. population lag behind other
developed countries who spend less on healthcare but more on
social programs that address poverty and SDOHs. It is hard to
imagine that the U.S. can begin to address the critical issues of
health disparities, underlying SDOHs, and universal coverage
without reining in healthcare costs.

3. What We Have Learned About
Healthcare Cost Containment
Historically, healthcare payers and policies have targeted
healthcare prices by using standardized fee schedules, limiting
price growth rates, and encouraging use of cheaper goods (e.g.
generic medications) and services (physician office rather than
emergency room). The results have been disappointing. In
1992, Medicare changed physician payments from a percent
of billed charges to standardized fee schedules based on
expected resources used. In subsequent years (1993-98), while
fees remained relatively controlled, volume and intensity of
physician services increased more than 30%, resulting in an
overall increase in spending for physician services [14]. In
1997, the Balanced Budget Act (BBA) established a
sustainable growth rate (SGR) which tied increases in total
physician payments to real, per-capita gross domestic product
(GDP). This global budget cap was ultimately unsuccessful
when the U.S. Congress repeatedly delayed implementation of
necessary cuts to physician payments, and ultimately ditched
the program because of immense political pressure from
providers. Simply put, price controls in the U.S. have not
worked.
3.1. Prescription Drugs
Americans spent an estimated $360 billion on prescription
drugs in 2019 (about 9.5% of all healthcare expenditures), and
these costs are projected to grow at a rate of 4-6% per year for
the foreseeable future [15]. To control costs, most payers
strongly incentivize patients to select generics or accept
therapeutic substitution (using chemically different drugs with
same expected clinical effect). While generic and therapeutic
substitution target drug prices, they do not address overall
drug utilization. The recent onslaught of direct-to-consumer
marketing of expensive pharmaceuticals and biologicals will
tend to countermand and offset price control efforts. Even if
the U.S. could bring prescription drug spending in line with
Canada (about a 30% reduction in per capita drug spending- a
daunting challenge), this would only reduce national health
expenditures by about 3% [16]. Reducing spending on
pharmaceuticals and biologicals, which has received much
attention in the U.S. Congress, is an important incremental
step but does not solve the U.S. healthcare cost problem.
Viewing drug costs as a critical tool to support population
health should force providers to use them judiciously, relying
on
evidence-based
formularies,
alongside
disease
management protocols and pathways where available.

3.2. Administrative Simplification
Administrative simplification has been espoused by many
as a cost saving opportunity. The estimated annual cost to U.S.
physician practices for interacting with health plans is $31
billion or about 14% of total collections [17]. Hospital
administrative costs accounted for 25% of U.S. hospital
expenditures ($215 billion in 2011), far higher than any other
country [18]. In addition, average insurer administrative costs
are estimated at 12.4% of premiums [19]. Unfortunately, there
is limited evidence that simplification efforts implemented in
recent rounds of U.S. healthcare reform have reduced
administrative costs [20]. On the contrary, some recent cost
containment efforts have actually increased the complexity
and costs of gathering and reporting of appropriate data. FFS
payment creates an enormous amount of administration that
will remain until we move to simplified payment models (i.e.
full risk) and metrics that matter.
3.3. Healthcare Fraud and Abuse
Healthcare fraud is knowingly deceiving someone or
misrepresenting information in order to receive payment,
while abuse involves provision of services that are
inconsistent with accepted medical, business or fiscal
practices. The National Health Care Anti-Fraud
Association estimates that health care fraud and abuse costs
the U.S. 3-10% of its’ healthcare spending ($68 - $230
billion annually) [21]. Under the ACA, the U.S. federal
government significantly ramped up their fraud and abuse
operations, collecting about $2.4 billion in health care fraud
judgments and settlements in 2017. While this is a
substantial number, it still represents a very small fraction
(0.3%) of current Medicare spending ($706 billion in 2017).
Having a reimbursement system that does not reward
volume, will go a long way in minimizing fraud and abuse.
3.4. Medical Malpractice
Medical malpractice in the U.S., including settlements,
legal and administrative costs and defensive medicine, costs
between $55.6 - $200 billion annually (2.4% – 10% of health
spending). Ample evidence also indicates that the U.S. tort
system does not compensate all patients equitably, [22]
rapidly or efficiently [23] and may hamper efforts to improve
patient safety [24] and lead to unnecessary tests and
procedures [25]. To date, the data suggests that tort reforms
have had an extremely limited impact on medical malpractice
payments and overall healthcare costs [26].
3.5. Provider Risk
Shifting risk to providers has shown some promise for cost
control. In the 1980s Health Maintenance Organizations
(HMOs) used restricted provider panels, capitated payments
(per member per month), and organized care protocols for cost
control. Subsequently, HMOs lost popularity and became less
effective in their cost containment efforts for two reasons.
First, primary care physicians with responsibility for
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managing a patient’s overall care were initially referred to as
“gatekeepers” rather than “patient advocates”. This very
unfortunate label reinforced the lingering public concern that
HMOs were focused on limiting choice and services to save
money, rather than providing effective, cost efficient and
comprehensive care. Second, state and federal courts undercut
HMO cost control through a series of rulings, forcing them to
pay for member use of non-HMO providers (see, for example,
Moran v. Rush Prudential HMO). Even more devastating was
the U.S. Supreme Court decision to uphold “any willing
provider laws”, reinforcing the entitlement mentality of
enrollees.
In today’s U.S. marketplace, payers have moved beyond
simple capitation, to a system that combines global payments
with financial incentives for patient access, quality of care,
and health outcomes. In addition, use of better data systems
and risk-adjustment models to account for the health of
covered lives arguably generates more equitable payments
than those in the 1980s and 1990s. The overall cost savings
that can be expected with full-risk global payment systems is
still unknown. An evaluation of capitated Medicaid managed
care programs noted cost savings ranging from 2 – 19%
compared to Medicaid FFS, mainly due to reduced inpatient
care [27]. Research recently published in the New England
Journal of Medicine demonstrated that global budget
contracts with quality incentives can ultimately drive
significant cost savings (5.9 – 9.1% of average costs) and
quality improvement, but gains may take several years to be
realized [28].
Because many providers are too small to assume substantial
financial risk, Medicare has pursued more limited pay for
performance (P4P) programs. Hospitals currently pay
substantial penalties for hospital acquired conditions (HACs)
and unplanned readmissions under Medicare’s hospital P4P
programs (close to $1 billion in 2017). Physicians also face
financial incentives to improve quality and lower costs under
the Medicare Access and CHIP Reauthorization Act of 2015
(MACRA) [29]. Unfortunately, P4P imposes modest revenue
decreases that can generally be offset by increased volume and
‘careful coding’. Arguably, with full alignment of incentives,
providers can be more engaged in meaningfully addressing
quality and cost.
3.6. Larger Risk Pools
Larger risk pools create efficiencies and share risk among a
larger group of beneficiaries. Authors of the ACA recognized
that risk pooling could provide significant cost savings,
mandating state-level health insurance exchanges to pool risk.
To prevent adverse selection, where only the sickest enrollees
end up in the pool, the ACA also included an individual
mandate, requiring everyone to carry health insurance.
Eliminating the individual mandate jeopardizes the ability of
exchanges to control premiums. While many argue that it is
unfair to require Americans to purchase health insurance, car
insurance is compulsory in most states [30], and we would
argue that most who don’t purchase health insurance are
counting on someone else (e.g. hospitals and/or Medicaid) to
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pick up the bill if they have a significant health crisis or illness,
requiring expensive care.
Examining the range of strategies available to federal and
state policymakers, we see very little evidence that specific
policies or interventions will significantly reduce cost,
especially under our FFS system, where volume makes up for
cuts. Global risk payments hold the greatest promise for real
cost containment because they can drive true delivery system
reform.

4. Health Insurance Coverage Is Moving
in the Wrong Direction
Recent attempts to control healthcare insurance costs have
resulted in the rapid proliferation of high deductible health
plans (HDHPs) and the introduction of “skinny plans”,
shifting risk to consumers and leaving an increasing number
of insured Americans financially vulnerable. In addition, even
after the ACA, 13.7% of adults still lack health insurance (Q4
2018), and these numbers are once again climbing. The rapid
growth of the underinsured and the recent uptick in the
uninsured is alarming many and has led to the “Medicare for
All” movement.
4.1. Underinsurance and Uninsured
Since 2007, enrollment in high-deductible health plans
(HDHPs) among employed adults age 18-64 has skyrocketed
(from 5% to 30%) and continues to rise [31]. HDHPs are
popular because their premiums are much lower than
traditional plans, but that ‘affordability’ is driven by limited
(“narrow”) provider networks and high deductibles (e.g.
$2000 - $5000/year).
HDHPs seek to engage individuals and make them smart
consumers. As demonstrated by the classic Rand Health
Insurance Experiment study, however, individuals with high
out-of-pocket costs are likely to forego high value care that
improves and preserves health, not just discretionary low
value services [32]. High deductibles may also be a significant
challenge for low-income individuals. So – most of the
millions of low-income Americans who gain coverage
through the ACA marketplaces are part of the growing
underinsured population in our country, placing them at risk
for foregoing necessary medical care or facing medical
bankruptcy. Individuals with chronic conditions, even those
with higher incomes, may also forego important medications
and healthcare prior to meeting their deductible making this a
middle class (and above) issue.
HDHPs also raise concerns about the wisdom of placing so
much decision-making responsibility on patients. Enrollees
are bombarded with data profiling provider costs and quality
and offering diagnostic and therapeutic options. A recent
comparison of hospital ratings from four different sources
found that only 10% of the 844 hospitals rated as high
performers by one rating system were rated as a high
performer by the other rating systems [33]. It is little wonder
that consumers find it difficult to incorporate these data in
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their decision-making.
4.2. Uninsured
While the ACA dramatically increased coverage between
2010 and 2017, many individuals still lack health insurance,
and uninsurance is once again on the rise [2]. The Supreme
Court’s decision to allow states to opt out of Medicaid (2012)
and the Trump Administration’s decision to offer a wide range
of exemptions from individual mandate penalties (2018) and
lowering penalties to $0 (2019) have weakened the impact of
the ACA on coverage.
Presently there are 37 million uninsured in the U.S. and
increasing [34]. Most are U.S. citizens (80%), from childless
households (66.6%), between the ages of 18 and 49 (64.5%)
and working (82.4%). Many have incomes below 200% of
the federal poverty line (57%) and reside in states that did not
expanded Medicaid (50.8%). About 25% of the currently
uninsured are eligible for Medicaid, and another 10.4% are
eligible for a marketplace plan with generous subsidies. This
means many uninsured have not “opted in” for various
reasons and should be targeted. Better Medicaid recruitment
and retention methods could substantially increase coverage
rates. It is also likely that additional states participating in
Medicaid expansion will also have a beneficial impact on
coverage rates.

5. Principles That Should Define a Future
Healthcare System
Clearly the U.S. healthcare system is faltering. The cost of
healthcare as a percentage of GDP continues to increase. U.S.
healthcare costs are unsustainable. At the same time the
number of uninsured and underinsured are substantial and
rising. The debate over U.S. healthcare reform has been too
narrow and predominantly driven by politics and ideology. It
needs to be expanded, focusing on the questions of how much
Americans pay (and can afford), how they pay (to drive
change) and what they get. From our review of policy and data
we have defined ten principles that should govern
comprehensive reform of the U.S. healthcare system.
Principle 1. Universal or near-universal coverage. The cry
for “Medicare for All” is really about increasing concerns over
access to comprehensive and affordable care, rather than
Medicare itself. This is as much about the underinsured as it is
about the uninsured.
Universal coverage will certainly rectify our moral
dilemma about healthcare being a human right. Expanding the
risk pool will also potentially moderate rate increases for
purchasers of insurance.
Principle 2. Comprehensive coverage of high value care.
Access to and coverage of high value care, which improves
and preserves health must be available to all. This can be
achieved and facilitated through a standard benefit package,
with modest deductibles and co-pays. Excessive out-of-pocket
costs that discourage use of high value care are
counterproductive. Low income individuals and people with

chronic illnesses should have their out-of-pocket costs
minimized, subsidized or even waived.
Principle 3. Enhanced benefits purchased with post-tax
dollars. Individuals should be able to, at their own expense
using post tax dollars, purchase additional benefits beyond
those offered in the standard benefit package. Some would
argue that this leads to tiered healthcare. We would argue that
the U.S. already has 4 tiers: uninsured, under-insured,
adequately insured and luxuriously insured (growing segment
of concierge medicine). We would prefer 2 tiers: adequately
insured and those who wish to purchase even more benefits.
Principle 4. Provider and patient engagement and support.
Without widespread support from both providers and patients,
significant change will fail. Physicians must assume
responsibility for and take pride in a delivery system that
provides effective, affordable, and equitable healthcare.
Appropriate reimbursement systems for Medicare, Medicaid
and other government sponsored health insurance plans can be
a potent mechanism for engaging physicians. Likewise,
consumers must recognize that effective, affordable, equitable
healthcare is a critical public commodity that must be managed
for the benefit of all. Some choice, particularly choice of plan,
must be preserved; however, unfettered access that reflects the
entitlement of the indemnity era cannot be supported.
Principle 5. Global payments with appropriate risk
adjustment are necessary. Our current fee-for-service system
incentivizes ‘do more, get more’, rather than emphasizing
what matters: outcomes, cost, and patient care experience.
Global payments, by shifting risk to plans and providers,
encourages innovation and should catalyze changes in our
healthcare delivery model, focusing efforts on efficiency,
quality and satisfaction. One way that global budgets can be
achieved is through vouchers or per capita payments.
Vouchers might be purchased by individuals who receive
additional pay in lieu of healthcare benefits; employers might
offer vouchers as a healthcare benefit; Medicare and Medicaid
might be administered through a voucher system; and the
federal government could subsidize vouchers for low income
individuals. Vouchers must fully cover the basic benefit
package (Principle #2). To adequately compensate for
variation in enrollee health, appropriate risk adjustment needs
to be used. Risk adjusting global payments (vouchers) will
level the playing field: discouraging providers and plans from
cherry-picking patients associated with more generous
premium margins (premium minus cost) and adequately
compensating those who serve high-needs patients (such as
those with challenging social determinants of health). A
voucher system does not necessarily disrupt our current
insurance system. Vouchers could be used to purchase
coverage through insurance companies or purchase coverage
directly from a provider system or network.
Principle 6. Provider incentives for efficient, effective and
patient-centered care. Alternative payment models that not
only offer global payments with appropriate risk adjustment,
but also include direct incentives for quality, access and
outcomes, can catalyze changes in our delivery system,
pressing for value and minimizing nonproductive and futile
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care. These models of payment should also encourage
providers to manage and minimize administrative costs and
discourage fraud and abuse. Aggressive competition among
providers based on quality, patient satisfaction and access is
necessary and essential to assure consumers that providers are
not skimping on care. Providers will understand and respond
much better to clear and direct incentives rather than
overwhelmingly burdensome regulations.
Principle 7. Healthcare system consolidation must be
allowed and supported. Large integrated networks and
systems can provide comprehensive, coordinated and
integrated services, align incentives to drive efficiency, safety,
quality and satisfaction, serve sufficient numbers to manage
risk, and be geographically dispersed to offer easy access.
Consolidation combined with quality and price competition,
what Enthoven called managed competition [35], creates
countervailing market power on both purchaser and supplier
sides that can support cost control, improved health outcomes
and patient-centered care. Such entities are not just theoretical.
Kaiser-Permanente, Geisinger Health, and Intermountain
Health, among others, serve large defined populations and
have demonstrated that they can deliver value, quality and
efficiency. The Department of Justice is often opposed to
consolidation because of presumed impact on prices. It may be
true that consolidation under FFS often results in increased
prices; this is not necessarily the case with global payments.
Principle 8. Clear information and consumer choice.
Consumers should be offered clear, concise and easily
understandable data, along with incentives that encourage
sound choice among competing plans, based on quality,
accessibility and satisfaction. In addition, performance
measures should be adequately adjusted for patient complexity,
so that consumers can make fair comparisons of providers.
State and Federal governments can and should impose some
licensing requirements on plans and require timely reporting
of consumer-centric information.
Principle 9. Investment in evidence-based health system
innovation. We need to know more about what works and does
not work in our health system both clinically and organizationally.
We spend a tremendous amount of money to develop treatments
and programs, but relatively little to understand their
dissemination, implementation and impact in the populations we
serve. We desperately need to develop strong evidence on what
works and use that evidence to drive further innovation.
Principle 10. Responsible and realistic cost control. Global
budgets can bend the cost curve effectively, but this must be
done gradually enough to avoid major disruptions to access
and quality of care. Providers need time to construct and
mature appropriate information systems and delivery models.
We need to set an acceptable, achievable target for healthcare
expenditures as a percentage of GDP and a timeline for
achieving this cost control that is not pushed off course by
special interest lobbying efforts. Reaching this target can free
up much-needed dollars for other investments; federal and
state governments will be able to fund other high-priority
projects like education and infrastructure, while employers
can re-invest in their companies and/or their employees to
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enhance their competitive positions. Most importantly, if
healthcare costs are sufficiently reined in, we as a country can
put more focus on health and the Social Determinants of
Health and not just healthcare.

6. Conclusions
None of the principles we outline are new and unique.
Together, however, they provide strategic direction for the
changes our healthcare delivery system desperately needs. Not
adhering to these principles will doom reform efforts. We
must understand and accept that our healthcare system is
deteriorating, and incremental change will not suffice.
Comprehensive change will be difficult and incur opposition.
As a nation, we must muster the political courage to get the job
done. The cost of inaction is too high.
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